Experts in artificial intelligence and data science have predicted that the regulatory bodies of United States and Europe they will end up controlling the use of health algorithms for patient management. A kind of clinical trial like the one prior to the approval of drugs or vaccines that will value the usefulness of health data and its use in patients.
The ‘II Health Observatory Symposium: The Lessons of Covid-19’, organized by EL ESPAÑOL and Invertia, has brought together Bernabé Marcos Montes, Technology Architect and Innovation Center Data Engineering Lead de Accenture; and José María Castellano, Scientific Director of the HM Hospitales Research Foundation, to analyze the future of patient clinical data.
During the meeting, Castellano has predicted that, in a few years, “FDA and Europe will regulate that the algorithms that handle patient data “are verified with trials. Something useful to put in value tools such as the one launched between HM Hospitales and the MDI (from the United States) that predicted whether or not a patient should enter the emergency room with a single chest x-ray.
In addition, in his opinion, the management of Covid-19 would have changed a lot if the use of the data were more advanced. “Triage in emergency rooms would have been better managed” when the pandemic was at its highest. With this, it has coincided Marcos Montes who has assured that “knowing how to manage the data” would have helped a lot during the first wave.
And, there are not a few projects where artificial intelligence can be very useful. “Right now we have our own solutions to forecast patients with Parkinson’s risk. We are working with pilots that work very well and we want to extrapolate them to European projects. In the clinic, artificial intelligence solutions have to be tested “, he added.
Well it is true that HM Hospitals It works with advantage because, from its own technological infrastructure, they have an important network that manages all medical records and unifies them in the cloud. “We have 17 hospitals that share the computer system and all patient data. Everything is perfectly communicated: 4 million patients and 10 million analytics,” he has encrypted.
The use of the data
According to him Technology Architect and Innovation Center Data Engineering Lead de Accenture, the “science of data” can have a useful part in three different aspects: anticipating the demands of rural Spain, monitoring chronic diseases (such as diabetes) and in caring for dependent people.
In the same way, Marcos Montes has explained that artificial intelligence will automate attention and “speed up the process of identifying an anomaly” and that “it will make you respond faster.” “It is evolving a lot and we are collaborating more and more with the scientific part “, he explained.
But, as the own expert of Accenture, The problem with using data is that you have to manage it despite the bureaucratic obstacles that exist. In fact, he has assured that it is necessary to “lighten up” the bureaucracy in the use of data.
Marcos Montes has insisted that, although the data is an aid to the doctor, it gives tools to the patient himself to “manage” in an “autonomous” way certain aspects of the Health care.
“The current regulation of the data is very strict“He concluded by ensuring that data must be used ethically with the problem” that this entails. “Artificial intelligence introduces the concept of bias. There are diseases that do not have stigma or gender, but in which there is stigma, it is not necessary to categorize, and make an algorithm that is exempt from it, “he concluded.
Follow the topics that interest you